Ocuphire CEO says her post was ter­mi­nat­ed with no cause giv­en

Ocuphire Phar­ma, which is await­ing its first FDA ap­proval de­ci­sion in Sep­tem­ber, an­nounced that Mi­na Sooch will no longer be pres­i­dent and CEO.

No rea­son was giv­en in an SEC fil­ing on Fri­day morn­ing lay­ing out the lead­er­ship shake-up, which oc­curred Wednes­day. The CEO and pres­i­dent roles are be­ing filled on an in­ter­im ba­sis by board mem­ber Rick Rodgers, and a search firm is work­ing on a per­ma­nent re­place­ment, Ocuphire said in a press re­lease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER